Core Viewpoint - Trevi Therapeutics, Inc. (TRVI) shows significant upside potential with a mean price target of $21.22, indicating a 231.1% increase from the current price of $6.41 [1] Price Targets and Analyst Consensus - The average price target consists of nine estimates ranging from a low of $13.00 to a high of $29.00, with a standard deviation of $4.92, suggesting a variability in analyst predictions [2] - The lowest estimate indicates a potential increase of 102.8%, while the highest suggests a 352.4% upside [2] - A low standard deviation indicates strong agreement among analysts regarding the stock's price movement direction [9] Earnings Estimates and Analyst Optimism - Analysts exhibit strong agreement in revising TRVI's earnings estimates higher, which correlates with potential stock price increases [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 3.2%, with one estimate increasing and no negative revisions [12] - TRVI holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - Solely relying on price targets for investment decisions may not be prudent, as analysts' price targets can often be overly optimistic due to business incentives [3][8] - While price targets should not be ignored, they should be approached with skepticism, as they may not accurately predict stock price movements [10]

Core Viewpoint - Geo Group (GEO) shares have shown a 0.8% increase over the past four weeks, closing at $26.33, with analysts suggesting a potential upside of 58.8% based on a mean price target of $41.8 [1] Price Targets and Analyst Consensus - The average price target for GEO is derived from five short-term estimates, ranging from a low of $35.00 to a high of $50.00, with a standard deviation of $6.42, indicating a potential increase of 32.9% to 89.9% from the current price [2] - A low standard deviation suggests a strong agreement among analysts regarding the price movement of GEO, which can serve as a starting point for further research [9] Earnings Estimates and Market Sentiment - Analysts have shown strong agreement in revising earnings per share (EPS) estimates higher for GEO, which correlates with potential stock price increases [11] - Over the past 30 days, one estimate has increased, leading to a 3.4% rise in the Zacks Consensus Estimate for the current year [12] - GEO holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] Caution on Price Targets - While price targets are often sought after, they can mislead investors, as empirical research shows they rarely indicate actual stock price movements [7] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8] - Investors should approach price targets with skepticism and not rely solely on them for investment decisions [10]

Group 1 - Micron's shares have increased by 8.1% over the past four weeks, closing at $119.92, with a mean price target of $150.72 indicating a potential upside of 25.7% [1] - The mean estimate consists of 29 short-term price targets with a standard deviation of $25.58, where the lowest estimate is $75.00 (37.5% decline) and the highest is $200.00 (66.8% increase) [2] - Analysts show strong agreement on Micron's ability to report better earnings than previously predicted, which supports the potential for stock upside [4][11] Group 2 - The Zacks Consensus Estimate for Micron's current year earnings has risen by 11.2% over the past month, with eight estimates increasing and no negative revisions [12] - Micron holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting stock gains, they can provide guidance on price movement direction [14]

Group 1 - Kemper's shares have increased by 0.1% over the past four weeks, closing at $63.07, with a mean price target of $82.2 indicating a potential upside of 30.3% [1] - The average of five short-term price targets ranges from a low of $75.00 to a high of $90.00, with a standard deviation of $5.72, suggesting a potential increase of 18.9% to 42.7% from the current price [2] - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price movements, indicating a positive outlook for Kemper [11][12] Group 2 - The Zacks Consensus Estimate for the current year has increased by 0.1% over the last 30 days, with no negative revisions, reflecting optimism about the company's earnings prospects [12] - Kemper currently holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, suggesting a strong potential upside [13] - While the consensus price target may not be a reliable indicator of the extent of potential gains, it does provide a directional guide for price movement [14]

Core Viewpoint - VNET Group (VNET) shares have increased by 30.7% in the past four weeks, closing at $6.98, with a mean price target of $12.29 indicating a potential upside of 76.1% according to Wall Street analysts [1][11]. Price Targets and Analyst Estimates - The mean estimate consists of eight short-term price targets with a standard deviation of $5.54, indicating variability among analysts [2]. - The lowest estimate is $5.00, suggesting a 28.4% decline from the current price, while the highest estimate is $20.00, indicating a potential increase of 186.5% [2]. - Analysts' price targets can often mislead investors, as empirical research shows they rarely indicate actual stock price movements [7][10]. Earnings Estimates and Analyst Agreement - There is strong agreement among analysts regarding VNET's ability to report better earnings, with a positive trend in earnings estimate revisions, which historically correlates with stock price movements [4][11]. - Over the last 30 days, two earnings estimates for VNET have increased, leading to a 21.9% rise in the Zacks Consensus Estimate [12]. - VNET holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13]. Conclusion on Price Movement - While the consensus price target may not be a reliable indicator of VNET's potential gains, the implied direction of price movement appears to be a useful guide for investors [14].

Group 1 - Elastic (ESTC) closed at $82.69, with a 2.3% gain over the past four weeks, and a mean price target of $112.17 suggests a 35.7% upside potential [1] - The average of 24 short-term price targets ranges from a low of $75.00 to a high of $148.00, with a standard deviation of $15.45, indicating variability among analysts [2] - Analysts show strong agreement in revising EPS estimates higher, which correlates with potential stock price movements [11] Group 2 - The Zacks Consensus Estimate for the current year has increased by 68.8% over the past month, with nine estimates going higher and two lower [12] - ESTC holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting gains, they can indicate the direction of price movement [14]

分组1 - Vigil Neuroscience, Inc. (VIGL) closed at $7.93, with a 0.6% gain over the past four weeks, and a mean price target of $10 indicates a 26.1% upside potential [1] - The average price targets from analysts range from a low of $8.00 to a high of $22.00, with a standard deviation of $5.29, suggesting variability in estimates [2] - Analysts show strong agreement on VIGL's ability to report better earnings than previously predicted, which supports the potential for stock upside [4][11] 分组2 - Recent revisions in earnings estimates for VIGL have been positive, with one estimate moving higher and the Zacks Consensus Estimate increasing by 2.6% [12] - VIGL holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While the consensus price target may not be a reliable indicator of the stock's potential gain, it does provide a directional guide for price movement [14]

Core Viewpoint - Consensus Cloud Solutions, Inc. (CCSI) shows potential for upside with a mean price target of $27.4, indicating a 25.1% increase from the current price of $21.91 [1] Price Targets - The average price target consists of five estimates ranging from a low of $20.00 to a high of $37.00, with a standard deviation of $7.06, suggesting variability in analyst predictions [2] - The lowest estimate indicates a potential decline of 8.7%, while the highest suggests a 68.9% upside [2] Analyst Sentiment - Analysts are optimistic about CCSI's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which historically correlates with stock price movements [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 0.4%, with one estimate moving higher and no negative revisions [12] Zacks Rank - CCSI holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] Caution on Price Targets - While price targets are a common metric, they should be approached with skepticism as they can mislead investors; analysts often set overly optimistic targets due to business incentives [7][8][10]

Core Viewpoint - Oric Pharmaceuticals, Inc. (ORIC) has seen a significant stock price increase of 57.1% over the past four weeks, closing at $9.22, with analysts suggesting a potential upside of 105% based on a mean price target of $18.9 [1][11]. Price Targets and Analyst Estimates - The mean estimate consists of 10 short-term price targets with a standard deviation of $4.04, indicating variability among analysts [2]. - The lowest price target is $12.00, suggesting a 30.2% increase from the current price, while the highest target is $25.00, indicating a potential surge of 171.2% [2]. - A low standard deviation signifies a strong agreement among analysts regarding the stock's price movement [9]. Earnings Estimates and Analyst Agreement - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price increases [11]. - Over the last 30 days, two earnings estimates for ORIC have been revised upward, leading to a 7.8% increase in the Zacks Consensus Estimate [12]. - ORIC holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors [13]. Conclusion on Price Movement - While consensus price targets may not be entirely reliable, the direction indicated by these targets appears to be a useful guide for potential price movement [14].

Core Viewpoint - Qifu Technology, Inc. (QFIN) shows potential for upside with a mean price target of $54.8, indicating a 27.3% increase from the current price of $43.06 [1] Price Targets and Analyst Estimates - The mean estimate consists of four short-term price targets with a standard deviation of $4.14, suggesting a consensus among analysts [2] - The lowest estimate is $50.00, indicating a 16.1% increase, while the highest estimate is $58.50, suggesting a 35.9% increase [2] - Analysts' price targets should be approached with caution, as their reliability has been questioned [3][7] Earnings Estimates and Analyst Agreement - Strong agreement among analysts regarding QFIN's earnings prospects supports the potential for stock upside [4][11] - The Zacks Consensus Estimate for the current year has increased by 2.3% over the past month, with two estimates revised upward [12] - QFIN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Conclusion on Price Movement - While consensus price targets may not be entirely reliable, the direction they imply appears to be a good guide for potential price movement [14]